Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
STAT5B | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 1.79E5 | Evidence | O | ||||
STAT5B | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 1.08E5 | Evidence | |||||
STAT5B | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 9.66E4 | Evidence | |||||
STAT5B | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 9.37E4 | Evidence | O | ||||
STAT5B | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 8.52E4 | Evidence | |||||
STAT5B | KIT | KIT: Mast/stem cell growth factor receptor precursor | 4.90E4 | Evidence | |||||
STAT5B | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 4.56E4 | Evidence | |||||
STAT5B | INSR | INSR: Insulin receptor precursor | 3.97E4 | Evidence | |||||
STAT5B | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 3.55E4 | Evidence | |||||
STAT5B | CREBBP | CREBBP, CBP: CREB-binding protein | 1.55E4 | Evidence | |||||
STAT5B | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.21E4 | Evidence | |||||
STAT5B | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 8.23E3 | Evidence | |||||
STAT5B | STAT3 | 1.91E3 | Evidence | ||||||
STAT5B | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 626.0 | Evidence | |||||
STAT5B | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 564.0 | Evidence | |||||
STAT5B | LYN | LYN: Tyrosine-protein kinase Lyn | 373.0 | Evidence | |||||
STAT5B | JAK1 | 373.0 | Evidence | ||||||
STAT5B | CSK | CSK: Tyrosine-protein kinase CSK | 306.0 | Evidence | |||||
STAT5B | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 305.0 | Evidence | |||||
STAT5B | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 305.0 | Evidence | |||||
STAT5B | SYK | SYK: Tyrosine-protein kinase SYK | 305.0 | Evidence | |||||
STAT5B | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 286.0 | Evidence | |||||
STAT5B | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 243.0 | Evidence | |||||
STAT5B | HCK | N/A | 226.0 | Evidence | |||||
STAT5B | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 206.0 | Evidence | |||||
STAT5B | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 206.0 | Evidence | |||||
STAT5B | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 200.0 | Evidence | |||||
STAT5B | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 185.0 | Evidence | |||||
STAT5B | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 148.0 | Evidence | |||||
STAT5B | BMX | N/A | 147.0 | Evidence | |||||
STAT5B | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
STAT5B | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 119.0 | Evidence | |||||
STAT5B | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 115.0 | Evidence | |||||
STAT5B | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 110.0 | Evidence | |||||
STAT5B | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 101.0 | Evidence | |||||
STAT5B | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 85.20 | Evidence | |||||
STAT5B | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 82.50 | Evidence | |||||
STAT5B | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 80.50 | Evidence | |||||
STAT5B | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 74.9 | Evidence | |||||
STAT5B | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 73.20 | Evidence | |||||
STAT5B | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 72.70 | Evidence | |||||
STAT5B | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 65.6 | Evidence | |||||
STAT5B | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 65.30 | Evidence | |||||
STAT5B | DOK1 | DOK1: Docking protein 1 | 62.90 | Evidence | |||||
STAT5B | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 62.90 | Evidence | |||||
STAT5B | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 58.60 | Evidence | |||||
STAT5B | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 57.70 | Evidence | |||||
STAT5B | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 56.20 | Evidence | |||||
STAT5B | CRKL | CRKL: Crk-like protein | 56.20 | Evidence | |||||
STAT5B | VAV1 | VAV1, VAV: Proto-oncogene vav | 56.20 | Evidence | |||||
STAT5B | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 52.50 | Evidence | |||||
STAT5B | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 51.60 | Evidence | |||||
STAT5B | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 51.60 | Evidence | |||||
STAT5B | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 51.50 | Evidence | |||||
STAT5B | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 50.00 | Evidence | |||||
STAT5B | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 44.00 | Evidence | |||||
STAT5B | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 43.60 | Evidence | |||||
STAT5B | IRS2 | IRS2: Insulin receptor substrate 2 | 43.60 | Evidence | |||||
STAT5B | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 43.00 | Evidence | |||||
STAT5B | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 43.00 | Evidence | |||||
STAT5B | NCK2 | NCK2: Cytoplasmic protein NCK2 | 41.50 | Evidence | |||||
STAT5B | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 41.10 | Evidence | |||||
STAT5B | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 39.70 | Evidence | |||||
STAT5B | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 39.60 | Evidence | |||||
STAT5B | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 39.60 | Evidence | |||||
STAT5B | CCR5 | CCR5: CCR5 receptor (Fragment) | 39.60 | Evidence | |||||
STAT5B | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 39.10 | Evidence | |||||
STAT5B | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 38.10 | Evidence | |||||
STAT5B | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 38.10 | Evidence | |||||
STAT5B | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 38.10 | Evidence | O | ||||
STAT5B | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 35.40 | Evidence | |||||
STAT5B | H1FX | H1FX: Histone H1x | 35.40 | Evidence | |||||
STAT5B | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 34.80 | Evidence | |||||
STAT5B | GAB1 | GAB1: GRB2-associated-binding protein 1 | 34.80 | Evidence | |||||
STAT5B | LCP1 | LCP1, PLS2: Plastin-2 | 34.00 | Evidence | |||||
STAT5B | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 34.00 | Evidence | |||||
STAT5B | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 33.90 | Evidence | |||||
STAT5B | MET | MET: Hepatocyte growth factor receptor precursor | 32.70 | Evidence | |||||
STAT5B | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 31.20 | Evidence | |||||
STAT5B | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 31.20 | Evidence | |||||
STAT5B | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 30.10 | Evidence | |||||
STAT5B | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 29.70 | Evidence | |||||
STAT5B | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 29.20 | Evidence | |||||
STAT5B | WASPIP | N/A | 27.60 | Evidence | |||||
STAT5B | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 26.40 | Evidence | |||||
STAT5B | RELA | RELA, NFKB3: Transcription factor p65 | 26.00 | Evidence | |||||
STAT5B | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 26.00 | Evidence | |||||
STAT5B | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 26.00 | Evidence | |||||
STAT5B | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 25.70 | Evidence | |||||
STAT5B | DPF2 | DPF2, REQ, UBID4: Zinc finger protein ubi-d4 | 25.50 | Evidence | |||||
STAT5B | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 25.50 | Evidence | |||||
STAT5B | CD2AP | CD2AP: CD2-associated protein | 25.10 | Evidence | |||||
STAT5B | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 25.00 | Evidence | |||||
STAT5B | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 24.90 | Evidence | |||||
STAT5B | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 24.90 | Evidence | |||||
STAT5B | IRS1 | IRS1: Insulin receptor substrate 1 | 24.80 | Evidence | |||||
STAT5B | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 24.00 | Evidence | |||||
STAT5B | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 22.90 | Evidence | |||||
STAT5B | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 22.80 | Evidence | |||||
STAT5B | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 22.30 | Evidence | |||||
STAT5B | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 22.30 | Evidence | |||||
STAT5B | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 22.30 | Evidence | |||||
STAT5B | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 22.20 | Evidence | |||||
STAT5B | TERF2IP | TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 | 22.00 | Evidence | |||||
STAT5B | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 21.40 | Evidence | |||||
STAT5B | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 21.10 | Evidence | |||||
STAT5B | APS | SH2B2, APS: SH2B adapter protein 2 | 20.50 | Evidence | |||||
STAT5B | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 20.50 | Evidence | |||||
STAT5B | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 20.50 | Evidence | |||||
STAT5B | CRKRS | CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 | 20.50 | Evidence | |||||
STAT5B | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 20.30 | Evidence | |||||
STAT5B | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 19.70 | Evidence | |||||
STAT5B | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 18.90 | Evidence | |||||
STAT5B | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 18.60 | Evidence | |||||
STAT5B | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 18.10 | Evidence | O | ||||
STAT5B | EP300 | N/A | 17.80 | Evidence | |||||
STAT5B | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 17.60 | Evidence | |||||
STAT5B | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 17.50 | Evidence | |||||
STAT5B | LOC389305 | Uncharacterized protein ENSP00000349185 (Fragment) | 17.40 | Evidence | |||||
STAT5B | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 17.10 | Evidence | |||||
STAT5B | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 17.10 | Evidence | |||||
STAT5B | STAM2 | STAM2: Signal transducing adapter molecule 2 | 16.60 | Evidence | |||||
STAT5B | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 16.30 | Evidence | |||||
STAT5B | ABCF1 | N/A | 16.10 | Evidence | |||||
STAT5B | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 15.70 | Evidence | |||||
STAT5B | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 15.70 | Evidence | |||||
STAT5B | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 15.70 | Evidence | |||||
STAT5B | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 15.70 | Evidence | |||||
STAT5B | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 15.70 | Evidence | |||||
STAT5B | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 15.70 | Evidence | |||||
STAT5B | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 15.50 | Evidence | |||||
STAT5B | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 15.30 | Evidence | |||||
STAT5B | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.10 | Evidence | |||||
STAT5B | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 15.00 | Evidence | |||||
STAT5B | NMI | NMI: N-myc-interactor | 14.90 | Evidence | O | ||||
STAT5B | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 14.50 | Evidence | |||||
STAT5B | EPOR | EPOR: Erythropoietin receptor precursor | 14.50 | Evidence | |||||
STAT5B | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 14.40 | Evidence | |||||
STAT5B | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 14.30 | Evidence | |||||
STAT5B | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 14.10 | Evidence | |||||
STAT5B | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 14.10 | Evidence | |||||
STAT5B | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 14.10 | Evidence | |||||
STAT5B | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 13.50 | Evidence | |||||
STAT5B | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 13.50 | Evidence | |||||
STAT5B | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 13.40 | Evidence | |||||
STAT5B | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 13.20 | Evidence | |||||
STAT5B | HDAC3 | HDAC3: Histone deacetylase 3 | 12.60 | Evidence | |||||
STAT5B | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 12.60 | Evidence | |||||
STAT5B | OSTF1 | N/A | 12.00 | Evidence | |||||
STAT5B | MCM3 | MCM3: DNA replication licensing factor MCM3 | 12.00 | Evidence | |||||
STAT5B | JUN | JUN: Transcription factor AP-1 | 11.90 | Evidence | |||||
STAT5B | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 11.90 | Evidence | |||||
STAT5B | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 11.90 | Evidence | |||||
STAT5B | NULL | Ig lambda chain V-II region NEI | 11.70 | Evidence | |||||
STAT5B | EVL | EVL, RNB6: Ena/VASP-like protein | 11.70 | Evidence | |||||
STAT5B | GRB10 | N/A | 11.70 | Evidence | |||||
STAT5B | FADD | FADD, MORT1: Protein FADD | 11.70 | Evidence | |||||
STAT5B | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 11.70 | Evidence | |||||
STAT5B | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 11.70 | Evidence | |||||
STAT5B | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 11.60 | Evidence | |||||
STAT5B | FOXM1 | FOXM1, FKHL16, HFH11, MPP2, WIN: Forkhead box protein M1 | 11.50 | Evidence | |||||
STAT5B | IRF1 | IRF1: Interferon regulatory factor 1 | 11.50 | Evidence | |||||
STAT5B | RNF31 | ISGF3G, IRF9: Transcriptional regulator ISGF3 subunit gamma | 11.50 | Evidence | |||||
STAT5B | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 11.30 | Evidence | |||||
STAT5B | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 10.80 | Evidence | |||||
STAT5B | RASA4 | RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 | 10.80 | Evidence | |||||
STAT5B | COPA | COPA: Coatomer subunit alpha | 10.60 | Evidence | |||||
STAT5B | SYNGAP1 | SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP | 10.50 | Evidence | |||||
STAT5B | MAP2K3 | N/A | 10.40 | Evidence | |||||
STAT5B | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 10.30 | Evidence | |||||
STAT5B | GHR | GHR: Growth hormone receptor precursor | 10.30 | Evidence | |||||
STAT5B | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 10.30 | Evidence | |||||
STAT5B | PRLR | PRLR: Prolactin receptor precursor | 10.30 | Evidence | |||||
STAT5B | HDAC2 | HDAC2: Histone deacetylase 2 | 10.30 | Evidence | |||||
STAT5B | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 10.10 | Evidence | |||||
STAT5B | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 9.92 | Evidence | |||||
STAT5B | ESRRA | ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 | 9.88 | Evidence | |||||
STAT5B | GNB2L1 | Lung cancer oncogene 7 | 9.76 | Evidence | |||||
STAT5B | VCPIP1 | VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 | 9.73 | Evidence | |||||
STAT5B | VCAM1 | VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor | 9.55 | Evidence | |||||
STAT5B | HLA-DMA | DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP | 9.48 | Evidence | |||||
STAT5B | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 9.33 | Evidence | |||||
STAT5B | IRF2 | IRF2: Interferon regulatory factor 2 | 9.31 | Evidence | |||||
STAT5B | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 9.29 | Evidence | |||||
STAT5B | USP10 | USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 | 9.15 | Evidence | |||||
STAT5B | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 9.04 | Evidence | |||||
STAT5B | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 9.0 | Evidence | |||||
STAT5B | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 9.0 | Evidence | |||||
STAT5B | NCF2 | NCF2: Neutrophil cytosol factor 2 | 8.92 | Evidence | |||||
STAT5B | NUP153 | N/A | 8.74 | Evidence | |||||
STAT5B | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 8.72 | Evidence | |||||
STAT5B | L1CAM | L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor | 8.55 | Evidence | |||||
STAT5B | IL2RG | IL2RG: Cytokine receptor common gamma chain precursor | 8.46 | Evidence | |||||
STAT5B | PHB2 | PHB2, BAP, REA: Prohibitin-2 | 8.44 | Evidence | |||||
STAT5B | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 8.36 | Evidence | |||||
STAT5B | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 8.36 | Evidence | |||||
STAT5B | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 8.20 | Evidence | |||||
STAT5B | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 8.03 | Evidence | |||||
STAT5B | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 7.74 | Evidence | |||||
STAT5B | MAL2 | MAL2: Protein MAL2 | 7.72 | Evidence | |||||
STAT5B | PIAS1 | PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 | 7.68 | Evidence | |||||
STAT5B | INSRR | INSRR, IRR: Insulin receptor-related protein precursor | 7.54 | Evidence | |||||
STAT5B | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 7.38 | Evidence | |||||
STAT5B | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 7.18 | Evidence | |||||
STAT5B | PARVA | PARVA, MXRA2: Alpha-parvin | 7.17 | Evidence | |||||
STAT5B | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 7.17 | Evidence | |||||
STAT5B | MAP3K9 | MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 | 7.14 | Evidence | |||||
STAT5B | CEACAM1 | CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr | 7.12 | Evidence | |||||
STAT5B | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 7.12 | Evidence | |||||
STAT5B | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 6.83 | Evidence | |||||
STAT5B | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 6.81 | Evidence | |||||
STAT5B | S100A9 | S100A9, CAGB, CFAG, MRP14: Protein S100-A9 | 6.81 | Evidence | |||||
STAT5B | FLNB | FLNB, FLN1L, FLN3, TABP, TAP: Filamin-B | 6.63 | Evidence | |||||
STAT5B | GRAP | GRAP: GRB2-related adapter protein | 6.54 | Evidence | |||||
STAT5B | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 6.37 | Evidence | |||||
STAT5B | ALCAM | ALCAM, MEMD: CD166 antigen precursor | 6.37 | Evidence | |||||
STAT5B | BUB1 | 6.31 | Evidence | ||||||
STAT5B | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 6.26 | Evidence | |||||
STAT5B | IL6R | IL6R: Interleukin-6 receptor alpha chain precursor | 6.26 | Evidence | |||||
STAT5B | SRA1 | APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 | 6.11 | Evidence | |||||
STAT5B | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 6.11 | Evidence | |||||
STAT5B | ASB6 | ASB6: Ankyrin repeat and SOCS box protein 6 | 6.11 | Evidence | |||||
STAT5B | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 6.11 | Evidence | |||||
STAT5B | VDR | VDR, NR1I1: Vitamin D3 receptor | 5.99 | Evidence | |||||
STAT5B | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 5.77 | Evidence | |||||
STAT5B | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 5.76 | Evidence | |||||
STAT5B | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 5.74 | Evidence | |||||
STAT5B | CPSF1 | CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 | 5.74 | Evidence | |||||
STAT5B | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 5.73 | Evidence | |||||
STAT5B | IGFBP5 | IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor | 5.66 | Evidence | |||||
STAT5B | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
STAT5B | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 5.45 | Evidence | |||||
STAT5B | VCP | VCP: Transitional endoplasmic reticulum ATPase | 5.45 | Evidence | |||||
STAT5B | USP47 | USP47: Ubiquitin carboxyl-terminal hydrolase 47 | 5.45 | Evidence | |||||
STAT5B | GGCX | GGCX, GC: Vitamin K-dependent gamma-carboxylase | 5.28 | Evidence | |||||
STAT5B | ANXA6 | ANXA6, ANX6: Annexin A6 | 5.12 | Evidence | |||||
STAT5B | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 5.04 | Evidence | |||||
STAT5B | STIP1 | STIP1: Stress-induced-phosphoprotein 1 | 4.98 | Evidence | |||||
STAT5B | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 4.96 | Evidence | |||||
STAT5B | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 4.80 | Evidence | |||||
STAT5B | FRS2 | FRS2: Fibroblast growth factor receptor substrate 2 | 4.77 | Evidence | |||||
STAT5B | EDNRB | EDNRB, ETRB: Endothelin B receptor precursor | 4.68 | Evidence | |||||
STAT5B | PIAS4 | PIAS4, PIASG: E3 SUMO-protein ligase PIAS4 | 4.64 | Evidence | |||||
STAT5B | HSP90AA1 | Hsp89-alpha-delta-N | 4.63 | Evidence | |||||
STAT5B | PCNA | PCNA: Proliferating cell nuclear antigen | 4.55 | Evidence | |||||
STAT5B | TSHR | N/A | 4.55 | Evidence | |||||
STAT5B | RARS | RARS: Arginyl-tRNA synthetase, cytoplasmic | 4.46 | Evidence | |||||
STAT5B | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 4.46 | Evidence | |||||
STAT5B | SUPT5H | SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 | 4.00 | Evidence | |||||
STAT5B | SOCS2 | SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 | 3.96 | Evidence | |||||
STAT5B | VAV3 | VAV3: Protein vav-3 | 3.96 | Evidence | |||||
STAT5B | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 3.89 | Evidence | |||||
STAT5B | ZCCHC3 | ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 | 3.88 | Evidence | |||||
STAT5B | TNC | TNC, HXB: Tenascin precursor | 3.74 | Evidence | |||||
STAT5B | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 3.71 | Evidence | |||||
STAT5B | TNNC1 | TNNC1, TNNC: Troponin C, slow skeletal and cardiac muscles | 3.65 | Evidence | |||||
STAT5B | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 3.62 | Evidence | |||||
STAT5B | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 3.58 | Evidence | |||||
STAT5B | RELB | RELB: Transcription factor RelB | 3.52 | Evidence | |||||
STAT5B | CHGB | CHGB, SCG1: Secretogranin-1 precursor | 3.49 | Evidence | |||||
STAT5B | KPNA5 | KPNA5: Importin subunit alpha-6 | 3.45 | Evidence | |||||
STAT5B | PTPN11 | N/A | 3.39 | Evidence | |||||
STAT5B | AKR7A2 | AKR7A2, AFAR, AFAR1, AKR7: Aflatoxin B1 aldehyde reductase member 2 | 3.39 | Evidence | |||||
STAT5B | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.30 | Evidence | |||||
STAT5B | STAP2 | Uncharacterized protein ENSP00000317912 | 3.28 | Evidence | |||||
STAT5B | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 3.28 | Evidence | |||||
STAT5B | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 3.20 | Evidence | |||||
STAT5B | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 3.07 | Evidence | |||||
STAT5B | BCR | N/A | 2.93 | Evidence | |||||
STAT5B | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 2.93 | Evidence | |||||
STAT5B | KPNA6 | N/A | 2.93 | Evidence | |||||
STAT5B | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 2.91 | Evidence | |||||
STAT5B | PLEKHA1 | PLEKHA1, TAPP1: Pleckstrin homology domain-containing family A member 1 | 2.80 | Evidence | |||||
STAT5B | KCNJ12 | KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 | 2.75 | Evidence | |||||
STAT5B | SCARB2 | SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 | 2.75 | Evidence | |||||
STAT5B | KIR2DL3 | KIR2DL3, CD158B2, KIRCL23, NKAT2: Killer cell immunoglobulin-like receptor 2DL3 | 2.71 | Evidence | |||||
STAT5B | CAV1 | CAV1, CAV: Caveolin-1 | 2.66 | Evidence |